Article
Phenotypic and genetic heterogeneity of familial hyperkalaemic hypertension (Gordon syndrome).
Clinical and experimental pharmacology & physiology - 1 Dec 2001
Achard J M, Disse-Nicodeme S, Fiquet-Kempf B, Jeunemaitre X
Abstract excerpt
1. Familial hyperkalaemic hypertension (FHH), also called pseudohypoaldosteronism type II (PHA2) or Gordon syndrome, is a rare Mendelian-form of low-renin hypertension. The first cases of FHH were reported approximately 30 years ago and they described the peculiar biochemical abnormalities (i.e. hyperkalaemia and hyperchloraemic acidosis despite a normal glomerular filtration rate). 2. Since then, more than 90...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.